drugset / Trial / NCT00919451
Ciclosporin in the Management of Steroid Resistant Type 1 Reactions in Leprosy
Phase 2
Completed
16 enrolled
London School of Hygiene and Tropical Medicine
Alert Hospital, Ethiopia · collabArmauer Hansen Research Institute, Ethiopia · collabHomes and Hospitals of St Giles · collab
NaSingle-groupOpen-labelTreatment
Summary
Study 1B: Ciclosporin in the management of steroid resistant Type 1 Reactions in Leprosy Objective: A pilot study assessing the efficacy and safety of Ciclosporin as a second -line drug in patients with Type 1 Reactions who have not responded to a 12 week course of Prednisolone.
Timeline
- Start
- 2010-08
- Primary completion
- 2013-06
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 7.5 mg/kg | — |